Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA)

68 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2024.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12.1M shares of 55M outstanding shares and own 22% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4.7M shares), BlackRock, Inc. (1.58M shares), VANGUARD GROUP INC (1.48M shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (790K shares), GEODE CAPITAL MANAGEMENT, LLC (562K shares), STATE STREET CORP (453K shares), Parkman Healthcare Partners LLC (376K shares), GSA CAPITAL PARTNERS LLP (311K shares), Schonfeld Strategic Advisors LLC (271K shares), and PEDDOCK CAPITAL ADVISORS, LLC (235K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.